ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
5.43
-0.12 (-2.16%)
At close: May 31, 2024, 4:00 PM
5.42
-0.01 (-0.18%)
After-hours: May 31, 2024, 5:50 PM EDT
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $148.89 million as of May 31, 2024. Its market cap has decreased by -23.41% in one year.
Market Cap
148.89M
Enterprise Value
127.44M
1-Year Change
-23.41%
Ranking
Category
Stock Price
$5.43
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $148.89M, an increase of 391.39%. That is a compound annual growth rate of 14.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2024 | 148.90M | -2.17% |
| May 30, 2024 | 152.20M | - |
| May 29, 2024 | 152.20M | 0.73% |
| May 28, 2024 | 151.10M | -6.15% |
| May 24, 2024 | 161.00M | -5.46% |
| May 23, 2024 | 170.30M | 2.47% |
| May 22, 2024 | 166.20M | -0.12% |
| May 21, 2024 | 166.40M | -1.01% |
| May 20, 2024 | 168.10M | -1.12% |
| May 17, 2024 | 170.00M | -3.13% |
| May 16, 2024 | 175.50M | - |
| May 15, 2024 | 175.50M | 6.49% |
| May 14, 2024 | 164.80M | 2.74% |
| May 13, 2024 | 160.40M | -0.19% |
| May 10, 2024 | 160.70M | -4.06% |
| May 9, 2024 | 167.50M | 2.01% |
| May 8, 2024 | 164.20M | 1.67% |
| May 7, 2024 | 161.50M | 0.81% |
| May 6, 2024 | 160.20M | 1.14% |
| May 3, 2024 | 158.40M | 6.38% |
| May 2, 2024 | 148.90M | 1.85% |
| May 1, 2024 | 146.20M | -0.20% |
| Apr 30, 2024 | 146.50M | 1.88% |
| Apr 29, 2024 | 143.80M | 1.34% |
| Apr 26, 2024 | 141.90M | -0.91% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accuray | 155.81M |
| OptiNose | 154.98M |
| Biodesix | 154.83M |
| P3 Health Partners | 154.04M |
| MediWound | 152.25M |
| InfuSystem Holdings | 150.56M |
| Context Therapeutics | 150.00M |
| ProQR Therapeutics | 149.44M |